Skip to content

Treatment of chronic ischemic diseases of the lower limbs with Anterior superior iliac spine distraction

Treatment of chronic ischemic diseases of the lower limbs with Anterior superior iliac spine distraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072418
Enrollment
Unknown
Registered
2023-06-13
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ischemic disease of the lower limbs

Interventions

the group of ASISD:ASISD for the treatment of chronic defect diseases of the lower limbs

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Chronic ischemic disease of the lower limbs, or prolonged ulcers without improvement after regular treatment, such as patency of the popliteal artery; ? No severe coagulation dysfunction; ? Diabetes patients need to control their blood sugar normally. diabetes symptoms plus plasma glucose at any time = 11.1 mmol/L (200 mg/dl), or fasting plasma glucose level (FPG) = 7.0 mmol/L (126 mg/dl), or 2-hour blood glucose value (2hPG) in oral glucose tolerance test (OGTT) = 11.1 mmol/L (200 mg/dl); ? Those whose heart, lung, and kidney functions can tolerate surgery; ? The patient was informed and voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: ? The popliteal artery of the affected limb is completely blocked and no collateral circulation is established; ? Patients with arteriovenous diseases such as venous embolism and lymphangitis; ? Patients with severe organ dysfunction such as heart, lung, liver, and kidney; ? Acute complications of diabetes, such as diabetes hyperosmolar coma, diabetes ketosis and ketoacidosis, lactic acidosis, etc. ? Patients with malignant tumors; ? Pregnant or lactating women; ? Control fasting blood glucose above 8.0mmol/l; Non fasting blood glucose above 10.0mmol/l; ? Patients with immunosuppressive diseases and long-term use of hormones and other drugs cannot tolerate surgery and have poor compliance, making it difficult to control blood sugar and receive long-term treatment Osteoporosis fractures, pathological fractures.

Design outcomes

Primary

MeasureTime frame
Quantitative sensory testing, QST;visual analog scale,VAS;Inflammation index;extremity blood flow assessment;Wound healing time;Length of stay in hospital;Incidence of amputation;

Countries

China

Contacts

Public ContactWei Zairong

Affiliated Hospital of Zunyi Medical University

188116999@qq.com+86 152 0866 0008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026